Levonorgestrel (Postday)

DRUG2 trials

Sponsors

Bayer

Conditions

ContraceptionContraception, Postcoital

Phase 1

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel

CompletedNCT01096485

BayerContraception, Contraception, Postcoital

Start: 2009-02-28End: 2009-03-31Updated: 2013-06-11

Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel

CompletedNCT01096498

BayerContraception, Contraception, Postcoital

Start: 2009-02-28End: 2009-03-31Updated: 2013-06-11